David Eitel

Experience

• 

  Fidelity Investments

  Jan 1986 - Dec 1988

  Registered Representative (Series 7)

  Series 7 Rep with the retail stock trading division of Fidelity Investments of Boston. Executed trading instructions for clients, as well as educated walk in customers regarding the extensive line of Fidelity mutual funds and other financial products.

• 

  Ryerson / J.M. Tull Metals Co.

  Jan 1989 - Dec 2000

  Pricing Manager; Planning Mgr.; Purchasing Agent; Auditor; Analyst

  Held several positions over 11 years, including Pricing Manager over multiple product lines sold throughout the SE, Planning Manager in charge of forecasting and budgeting, Purchasing Agent for all pipe and tubing products, Financial Analyst for CEO working with overall corporate strategy; and Internal Auditor tasked with accounting and operational compliance of 15 locations in the Southeast.

• 

  Novartis Pharmaceuticals

  Jan 2001 - Nov 2003

  Manager of Business Planning & Analysis

  • Managed the budget and forecasting process of the ophthalmic unit, which included 7 functional areas from product development through sales• Performed monthly analysis and commentary of financial operating results and provided feedback to top management• Managed the Accounts Receivable department of 9 employees tasked with collecting $250 million in annual revenues• Assisted CFO with merger and acquisition prospect evaluations

• 

  Alimera Sciences, Inc.

  Nov 2003 - Jan 2012

  • Prepare $20+ million annual budgets, interim forecasts, and monthly financial analysis for ophthalmic drug research and development startup• Manage $50+ million, including moving funds around the world to support our global phase III clinical trial• Served in a pivotal role during product opportunity evaluations via financial modeling, including evaluation of potential partnerships• Supported IPO process and subsequent SEC filings as a public company • Created the accounting system from inception, including implementation of Great Plains• Managed annual audits by outside CPA firm, and provided periodic reports to the board of directors• Coordinated logistical support for $2 million dollar over-the-counter eye drop business• Prepared annual budgets, interim forecasts• Managed daily A/P and A/R functions

  • Director of Business Planning & Analysis

    Jan 2007 - Jan 2012

  • Controller

    Nov 2003 - Dec 2006
• 

  QSpex Technologies, Inc.

  Jan 2012 - Sept 2015

  Responsible for developing and implementing systems for reporting of all business unit financial and operational metrics from a series of satellite service centers. Head of the accounting department responsible for the reporting of financial results for Qspex Technologies Inc., a privately held company in the premium, custom spectacle lenses business. See more about this innovative technology at www.qspex.com. Year end audit preparations, financial systems planning for an expanding business, 2012 budget implementation & reporting using SAP By Design, consulting on back office interface for a new eye care product commercial roll out underway.

  • Director of Business Unit Analytics

    Jan 2015 - Sept 2015

  • Financial Controller

    May 2012 - Dec 2014

  • Contractor, Financial Management Professional

    Jan 2012 - May 2012
• 

  Encompass Pharmaceutical Svc

  Sept 2015 - Aug 2020

  Vice President of Finance and Administration

  The Chief Financial Officer for Encompass Pharmaceuticals, a privately held laboratory services and consulting firm in Peachtree Corners, GA.

• 

  Contemporary Marketing Group

  Sept 2020 - now

  Chief Financial Officer

  Chief Financial Officer at Contemporary Marketing Group, a provider of carpet, tile and wood flooring samples to home improvement stores across the country.